Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic–pharmacody...

Por Kerbusch, Thomas, Milligan, Peter A, Karlsson, Mats O
Publicado em 2004

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

Por Karlsson, Mats O., Lutsar, Irja, Milligan, Peter A.
Publicado em 2009

A population pharmacokinetic analysis of sildenafil citrate in patients with erectile dysfunction

Por Milligan, Peter A, Marshall, Scott F, Karlsson, Mats O
Publicado em 2002

Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulatio...

Por Kerbusch, Thomas, Wählby, Ulrika, Milligan, Peter A, Karlsson, Mats O
Publicado em 2003

Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis

Por Wählby, Ulrika, Thomson, Alison H, Milligan, Peter A, Karlsson, Mats O
Publicado em 2004

Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children

Por Walsh, Thomas J., Driscoll, Timothy, Milligan, Peter A., Wood, Nolan D., Schlamm, Haran, Groll, Andreas H., Jafri, Hasan, Arrieta, Antonio C., Klein, Nigel J., Lutsar, Irja
Publicado em 2010